MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Text entry as a digital outcome in Parkinson’s disease patients (TEXT-PD): results from two exploratory studies

    L. Azevedo Kauppila, A. Rodrigues, F. Pona Ferreira, M. Leitão, A. Santos, D. Branco, H. Nicolau, J. Ferreira, T. Guerreiro (Torres Vedras, Portugal)

    Objective: To evaluate the feasibility and psychometric properties of text entry (TE) and touch metrics as digital outcomes for PD patients. Background: TE on smartphones…
  • 2023 International Congress

    Evaluation of cases of psychosis from opicapone safety data

    L. Guedes, I. Peixoto, K. Erb-Zohar, C. Novais, M. Sampaio, C. Santos, J. Graça, V. Vuca, P. Calero, H. Gama (Coronado, Portugal)

    Objective: Investigate the likelihood of association of Opicapone (OPC) with psychotic symptoms (other than hallucinations). Background: Neuropsychiatric symptoms frequently occur in Parkinson’s Disease (PD) patients,…
  • 2023 International Congress

    Axial impairment and bradykinesia are related to increased CSF sTREM2, a neuroinflammation biomarker, in Parkinson’s disease

    A. Brück, R. Ajalin, H. Al-Abdulrasul, H. Zetterberg, K. Blennow, E. Löyttyniemi, J. Rinne (Turku, Finland)

    Objective: To explore the association between Parkinson’s disease (PD) motor symptoms and CSF biomarkers for neuroinflammation and neurodegeneration. Background: Previous in vivo and post mortem…
  • 2023 International Congress

    Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

    A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

    Objective: aim of the study was to investigate whether diabetes mellitus influences nigrostriatal dopaminergic vulnerability in drug-naïve patients with early-stage Parkinson’s Disease (PD). Background: recently,…
  • 2023 International Congress

    Combined GWAS of Dementia with Lewy Bodies, REM-Sleep Behavior Disorder, Parkinson’s Disease and Alzheimer’s Disease

    P. Saini, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)

    Objective: To identify genetic variants that are either shared between or specific for Dementia with Lewy Bodies (DLB), REM Behavior Disorder (RBD), Parkinson’s disease (PD)…
  • 2023 International Congress

    Sexual health and sleep quality in women living with Parkinson’s disease: are we neglecting that?

    KCN. Nobrega, TSM. Martins, GFS. Santos, MEP. Piemonte (Sao Paulo, Brazil)

    Objective: To investigate the relationship between sexual health and sleep quality in PD. Background: Sexual dysfunction (SD) is a common yet under-reported, non-motor symptom (NMS)…
  • 2023 International Congress

    Olfactory neurons’ Substance P is highly expressed in Parkinson’s disease reflecting gastrointestinal dysfunction

    T. Schirinzi, D. Maftei, P. Grillo, R. Bovenzi, J. Bissacco, C. Simonetta, H. Zenuni, FM. Passali, S. Di Girolamo, A. Stefani, NB. Mercuri, R. Lattanzi, C. Severini (Rome, Italy)

    Objective: To elucidate the role of Substance P in PD through molecular characterization of patients’ olfactory neurons. Background: Substance P is a neuropeptide largely expressed…
  • 2023 International Congress

    Assessing akinesia domains during multitasking in Parkinson’s disease

    V. Dzialas, M. Banwinkler, M. Höhnig, T. van Eimeren (Cologne, Germany)

    Objective: To explore performance differences in single- versus dual-tasking conditions between healthy controls (HC) and Parkinson's disease (PD) patients. Background: Akinesia, comprising slowness (bradykinesia), reduction…
  • 2023 International Congress

    Spinal cord stimulation for gait in Parkinsons disease in subthreshold settings

    R. Carra, J. Menezes, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (Sao Paulo, Brazil)

    Objective: To assess optimal parameters for tonic spinal cord stimulation (SCS) for Parkinson’s Disease (PD) gait disorders in blinded settings. Background: SCS is a promising…
  • 2023 International Congress

    Associations of IL-1β and IL-6 gene polymorphisms with Parkinson’s disease(PD)

    M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj, S. Fezai (Tunis)

    Objective: We aim to explore the associations of IL-1β and IL-6 gene polymorphisms with the pathogenesis of PD and with clinical features of motor and…
  • « Previous Page
  • 1
  • …
  • 349
  • 350
  • 351
  • 352
  • 353
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley